GlassScriptPhysician profile
Brian T Goss
NPI 1952887564
$4,093.26
in general payments reported to CMS, 2019-2025
21 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $1,180 · 2023: $1,005 · 2024: $1,236 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,376 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.04 |
| Education | $245.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,195.84 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $873.17 | 2021-2024 | Xtandi, Myrbetriq |
| Teleflex LLC | $712.06 | 2021-2023 | Urolift |
| Pfizer INC. | $207.92 | 2023-2025 | |
| Urovant Sciences INC | $165.29 | 2021-2022 | |
| Axonics, INC. | $144.02 | 2023-2024 | Axonics |
| Tolmar Pharmaceuticals, INC. | $96.08 | 2021-2022 | |
| Dentsply Ih Ab | $92.49 | 2024 | Lofric |
| Abbvie INC. | $88.09 | 2024-2025 | |
| Myovant Sciences INC. | $86.04 | 2022 | |
| Tolmar, INC. | $81.52 | 2023-2024 | |
| Medtronic, INC. | $70.44 | 2022-2023 | Interstim |
| Boston Scientific Corporation | $63.53 | 2025 | Axonics |
| Bluewind Medical | $46.44 | 2024 | Revi |
| Ferring Pharmaceuticals INC. | $33.52 | 2024 | Adstiladrin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $31.22 | 2024 | N.A. |
| Merck Sharp & Dohme LLC | $30.31 | 2023 | Lynparza, Keytruda |
| Convatec INC. | $20.92 | 2022 | |
| Janssen Biotech, INC. | $20.15 | 2022 | |
| Blue Earth Diagnostics | $17.56 | 2021 | |
| Halozyme INC | $16.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.